NCT04747912 2026-03-30
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
University of Chicago
Phase 2 Suspended
University of Chicago
University of Texas Southwestern Medical Center
Shanghai Jiao Tong University School of Medicine
Nordic Society for Pediatric Hematology and Oncology